Our ever-popular Palliative Care McGill Continuing Professional Development (CPD) Day took place (In-person and online) on November 21, 2025.
For more information on the event, see our interview with the director of CPD Day, Dr. Golda Tradounsky.
View the CPD Day 2025 agenda here: 
Agenda (EN) Agenda (FR)
Key topics of CPD Day 2025 included:
Total pain | Opioid neurotoxicity | Advocacy | Ketamine | Substance use disorders | Buprenorphine | Ethics | Cannabinoids
Overall Learning Objectives
At the conclusion of this activity, participants will be able to:
-
In the context of pain at the end of life, describe total pain, and identify strategies to manage opioid neurotoxicity
-
In the context of pain management at the end of life, formulate plans for the use of cannabinoids and for buprenorphine
-
Outline and apply core ethical principles to guide ethical decision-making
-
Cite key considerations for the use of ketamine as an antidepressant in end-of-life patients
-
Describe treatment approaches for palliation in patients with a history of substance use disorder
-
Summarize resources to advocate for people at the end of life, including highly vulnerable populations